Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Alphosyl HC cream
1305020I0BCAAAD
|
Alphosyl HC | Coal tar and corticosteroid preparations | Skin | No data available |
|
Alphosyl lotion
1305020C0BHABBB
|
Alphosyl (Topical) | Tars | Skin | No data available |
|
Altargo 10mg/g ointment
1310011AABBAAAA
|
Altargo | Retapamulin | Skin | No data available |
|
Aluminium oxide 38% paste
1306010A0AAAAAA
|
Aluminium oxide | Aluminium oxide | Skin | No data available |
|
Aluminium oxide 52% paste
1306010A0AAABAB
|
Aluminium oxide | Aluminium oxide | Skin | No data available |
|
Aluminium sulfate 20% liquid
1310050A0AAAAAA
|
Aluminium sulfate | Aluminium sulfate | Skin | No data available |
|
Aluminium sulfate 20% spray
1303000ABAAAAAA
|
Aluminium sulfate | Aluminium sulfate | Skin | No data available |
|
Ambre Solaire Total screen intolerance milk SPF 60
130801000BBLBA0
|
Proprietary compound preparation BNF 1308010 | Other sunscreening preparations | Skin | No data available |
|
Ambre Solaire UV Sensitive protection spray SPF 50+
130801000BBPJA0
|
Proprietary compound preparation BNF 1308010 | Other sunscreening preparations | Skin | No data available |
|
Amorolfine 0.25% cream
1310020A0AAABAB
|
Amorolfine hydrochloride | Amorolfine hydrochloride | Skin | No data available |
|
Anaflex 10% cream
1310050R0BBABAB
|
Anaflex (Topical) | Polynoxylin | Skin | No data available |
|
AnateP 400mg tablets for cutaneous solution
1311060Q0BDAAAC
|
AnateP | Potassium permanganate | Skin | No data available |
|
Anethaine 1% cream
1303000A0BBAAAB
|
Anethaine | Tetracaine hydrochloride | Skin | No data available |
|
Anglian Pharma 0.5% antiseptic first aid cream
1310050D0BJAAAA
|
Anglian Pharma | Cetrimide | Skin | No data available |
|
Antazoline 2% ointment
1303000C0AAAAAA
|
Antaz hydrochloride (Topical) | Antazoline hydrochloride | Skin | No data available |
|
Anthisan Plus Sting Relief spray
1303000B0BFAAAK
|
Anthisan Plus | Benzocaine | Skin | No data available |
|
Anzupgo 20mg/g cream
1305030M0BBAAAA
|
Anzupgo | Delgocitinib | Skin | No data available |
|
Aqua-cool 0.5% cream
1303000AABDAAAA
|
Aqua-cool | Menthol | Skin | No data available |
|
Aqua-cool 1% cream
1303000AABDABAB
|
Aqua-cool | Menthol | Skin | No data available |
|
Aqua-cool 2% cream
1303000AABDACAC
|
Aqua-cool | Menthol | Skin | No data available |
|
AquaBar
130201000BBKICH
|
Proprietary compound emollients | Other emollient preparations | Skin | No data available |
|
Aquasept 2% skin cleanser
1311050U0BFAAAD
|
Aquasept | Triclosan | Skin | No data available |
|
Ascabiol Emulsion 25%
1310040C0BBAAAA
|
Ascabiol | Benzyl benzoate | Skin | No data available |
|
Aserbine cream
131107000BMAAAA
|
Proprietary compound preparation BNF 1311070 | Other desloughing agents | Skin | No data available |
|
Aserbine solution
131107000BMABAB
|
Proprietary compound preparation BNF 1311070 | Other desloughing agents | Skin | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.